Precongress Course 6
SIG Global and Socio-cultural aspects of (in)fertility
Willem Ombelet (Belgium), Virginie Rozée (France), Trudie Gerrits (The Netherlands), Françoise Shenfield (United Kingdom)
The development of ART has been accompanied for many years by growing globalisation and commercialisation. Several aspects include patchy state funding with a public/private disparity and increased competition, the growth of cross border reproductive care, and the compensation or remuneration in “third party” ART whether by gametes donation or surrogacy that creates a kind of new reproductive labour and a parallel bio-economy.
This context raises many issues in terms of accessibility, (in)equalities, risks and benefits both for our patients, third parties involved (donors and surrogates) and policy makers .
The objective of this precongress course is to analyse some issues raised by the commercialisation of ART with specific examples and to discuss some models which might best benefit different patients who need fertility care.
Clinicians, nurses, scientists, psychologists, counsellors, social workers, researchers, managers, health care providers.
Educational needs and expected outcomes
To analyse the impact and consequences of commercialisation of reproductive medicine for patients, practitioners, health care providers, health care and society in general. The expected outcome is to critically analyse commercialisation in ART.